E! 12765 AD SCANNER Biomotif-KI
| Reference number | |
| Coordinator | Biomotif AB |
| Funding from Vinnova | SEK 4 989 000 |
| Project duration | February 2019 - August 2021 |
| Status | Completed |
| Venture | Eurostars |
Important results from the project
** Denna text är maskinöversatt ** We have built 2 AD Scanner instruments that have been delivered to KI and VUMC. The goal was to be able to differentiate between AD patient and healthy through analysis of blood sample. This has been successfully implemented during the project.
Expected long term effects
** Denna text är maskinöversatt ** The results obtained represent a proof of principle for the AD Scanner project. We will start discussions with our partners regarding commercialization plans.
Approach and implementation
The obtained results represent a proof of principle of the AD Scanner project. Currently KI and Biomotif together with VUMC continue to analyze individual AD and Healthy samples. The AD Scanner results will be compared with other AD biomarkers, and the sensitivity as well as specificity of the AD Scanner method will be determined.